Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Theratechnologies (TH.TO)

Theratechnologies (TH.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 213,327
  • Shares Outstanding, K 77,013
  • Annual Sales, $ 63,216 K
  • Annual Income, $ -12,496 K
  • 60-Month Beta 1.51
  • Price/Sales 2.46
  • Price/Cash Flow N/A
  • Price/Book 7.62
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.20
  • Most Recent Earnings -0.06 on 02/29/20
  • Next Earnings Date 07/15/20
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/20
See More
  • Average Estimate 0.01
  • Number of Estimates 1
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +116.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.38 +18.49%
on 06/11/20
3.71 -23.99%
on 06/22/20
+0.46 (+19.49%)
since 06/05/20
3-Month
2.27 +24.23%
on 04/09/20
4.17 -32.37%
on 04/23/20
+0.55 (+24.23%)
since 04/07/20
52-Week
1.93 +46.11%
on 03/18/20
6.72 -58.04%
on 07/08/19
-3.92 (-58.16%)
since 07/05/19

Most Recent Stories

More News
Theratechnologies Confirms Bioequivalence of New Tesamorelin Formulation

sBLA expected to be filed in early 2022

TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)
Theratechnologies Announces Ibalizumab Inhibits HIV-2 In Vitro

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that data presented at the 23 International AIDS Conference virtual...

THERF : 3.8000 (+4.68%)
TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)
Thinking about buying stock in SINTX Technologies, China Automotive Systems, Athersys Inc, Theratechnologies, or Biocept Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SINT, CAAS, ATHX, THTX, and BIOC.

ATHX : 2.75 (+2.23%)
BIOC : 0.7650 (+19.76%)
TH.TO : 2.82 (+1.81%)
New Data Show Theratechnologies' SORT1+ Technology is Effective in Many Treatment-Resistant Cancers

Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptor

TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)
Theratechnologies to Present at the RBC Capital Markets Global Healthcare Conference on May 19, 2020

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that management will present at the RBC Global Healthcare Conference on...

THERF : 3.8000 (+4.68%)
TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)
Theratechnologies to Make Oral Presentation on Oncology Platform During AACR Virtual Annual Meeting

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it will make an oral presentation on new results from its sortilin...

THERF : 3.8000 (+4.68%)
TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)
Theratechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Theratechnologies Inc., or Theratechnologies (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today that Paul Levesque, the current President and Chief Executive Officer...

THERF : 3.8000 (+4.68%)
TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)
Theratechnologies Announces Financial Results for the First Quarter of 2020

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced its financial results for the first quarter ended February 29, 2020.

THERF : 3.8000 (+4.68%)
THTX : 2.06 (+0.98%)
TH.TO : 2.82 (+1.81%)
Visceral Fat is a Predictor of Liver Fibrosis and Fibrosis Progression in People Living With HIV

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that Dr. Lindsay Fourman, from Harvard Medical School, presented...

THERF : 3.8000 (+4.68%)
TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)
Change to Theratechnologies Management

Paul Lévesque will be appointed as President and CEO, replacing Luc Tanguay, who is retiring

THERF : 3.8000 (+4.68%)
TH.TO : 2.82 (+1.81%)
THTX : 2.06 (+0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 2.95
1st Resistance Point 2.89
Last Price 2.82
1st Support Level 2.71
2nd Support Level 2.59

See More

52-Week High 6.72
Fibonacci 61.8% 4.89
Fibonacci 50% 4.32
Fibonacci 38.2% 3.76
Last Price 2.82
52-Week Low 1.93

See More

Business Summary

Theratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. The company mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar